| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 06/12/2013 | CN103145698A Preparation method of Rivaroxaban midbody and novel synthetic method of Rivaroxaban |
| 06/12/2013 | CN101273013B Sulfonamide derivative having PGD2 receptor antagonistic activity |
| 06/11/2013 | US8461329 Isoquinoline derivative |
| 06/11/2013 | US8461328 Tricyclic heterocyclic compounds, compositions and methods of use thereof |
| 06/11/2013 | US8461188 Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use |
| 06/11/2013 | US8461185 P2X3 receptor antagonists for treatment of pain |
| 06/11/2013 | US8461157 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety |
| 06/11/2013 | CA2722102C Phenylpropionic acid derivative and use thereof |
| 06/11/2013 | CA2546101C N-acylsulfonamide apoptosis promoters |
| 06/11/2013 | CA2484209C Protein kinase modulators and methods of use |
| 06/11/2013 | CA2427334C Methods and compositions for the treatment of diseases of the eye |
| 06/06/2013 | WO2013082548A1 Oligonucleotides for treating expanded repeat diseases |
| 06/06/2013 | WO2013082490A1 Substituted anilines as ccr(4) antagonists |
| 06/06/2013 | WO2013082345A1 Aryl dihydropyridinone and piperidinone as mgat2 inhibitors |
| 06/06/2013 | WO2013080120A1 Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease |
| 06/06/2013 | WO2013079505A1 Aminopyrimidine derivatives as lrrk2 modulators |
| 06/06/2013 | WO2013079495A1 2-(phenyl or pyrid-3-yl) aminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/06/2013 | WO2013079494A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/06/2013 | WO2013079452A1 New bicyclic dihydroisoquinoline-1-one derivatives |
| 06/06/2013 | WO2013079425A1 Novel 2h-indazoles as ep2 receptor antagonists |
| 06/06/2013 | WO2013079350A1 Insecticidal triazinone derivatives |
| 06/06/2013 | WO2013079223A1 Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rorϒ, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune diseases |
| 06/06/2013 | WO2013078771A1 Poly (adp-ribose) polymerase inhibitor |
| 06/06/2013 | WO2013078523A1 Heterocyclic n-glycinyl-n-acyl hydrazone compounds, synthesis method, pharmaceutical compositions and treatment method |
| 06/06/2013 | WO2013057251A3 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 06/06/2013 | WO2013049726A3 Processes for making compounds useful as inhibitors of atr kinase |
| 06/06/2013 | WO2012150183A8 Crystalline sodium salt of an hiv integrase inhibitor |
| 06/06/2013 | WO2012074126A9 Bicyclic compound |
| 06/06/2013 | US20130144056 Human Adam-10 Inhibitors |
| 06/06/2013 | US20130144055 Benzene Sulfonamide Thiazole And Oxazole Compounds |
| 06/06/2013 | US20130143935 Stem cell differentiating agents and uses therefor |
| 06/06/2013 | US20130143927 Compounds that modulate intracellular calcium |
| 06/06/2013 | US20130143906 Substituted pyrimidinone-phenyl-pyrimidinyl compounds |
| 06/06/2013 | US20130143892 New compounds, pharmaceutical compositions and uses thereof |
| 06/06/2013 | US20130143885 Chemical inducers of neurogenesis |
| 06/06/2013 | US20130143883 Modulators for amyloid beta |
| 06/06/2013 | US20130143881 Hydrated Crystalline Forms of N-[3-fluoro-4-(oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
| 06/06/2013 | US20130143880 Positive allosteric modulators of mglur2 |
| 06/06/2013 | US20130143876 New piperidine derivatives, pharmaceutical compositions and uses thereof |
| 06/06/2013 | US20130143871 4-aminoquinazolin-2-yl-1-pyrrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitors |
| 06/06/2013 | US20130143870 Novel compounds |
| 06/06/2013 | US20130143863 New bicyclic dihydroisoquinoline-1-one derivatives |
| 06/06/2013 | US20130143862 Certain amino-pyridazines, compositions thereof, and methods of their use |
| 06/06/2013 | US20130143860 Guanidine compound |
| 06/06/2013 | US20130143843 Aryl dihydropyridinone and piperidinone mgat2 inhibitors |
| 06/06/2013 | US20130143841 Benzoheterocyclic anti-bacterial agents |
| 06/06/2013 | US20130142807 Compositions and methods for inhibition of the jak pathway |
| 06/06/2013 | US20130142758 Novel hydroxamates as therapeutic agents |
| 06/06/2013 | CA2857689A1 Aryl dihydropyridinones and piperidinones as mgat2 inhibitors |
| 06/06/2013 | CA2857405A1 Poly (adp-ribose) polymerase inhibitor |
| 06/06/2013 | CA2856946A1 Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rory, nr1f3) activity and for the treatment of chronic inflammatory and autoimmunediseases |
| 06/06/2013 | CA2856839A1 Substituted anilines as ccr(4) antagonists |
| 06/06/2013 | CA2856769A1 Novel 2h-indazoles as ep2 receptor antagonists |
| 06/06/2013 | CA2856453A1 Insecticidal triazinone derivatives |
| 06/06/2013 | CA2856334A1 Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease |
| 06/06/2013 | CA2850705A1 2- (phenyl or pyrid - 3 - yl) aminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/06/2013 | CA2850700A1 New bicyclic dihydroisoquinoline-1-one derivatives |
| 06/06/2013 | CA2850594A1 Aminopyrimidine derivatives as lrrk2 modulators |
| 06/06/2013 | CA2850593A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/05/2013 | EP2599774A1 Condensed ring pyridine compound |
| 06/05/2013 | EP2598500A1 Compositions and methods for inhibition of the jak pathway |
| 06/05/2013 | EP2598486A1 Bicyclic acetyl-coa carboxylase inhibitors |
| 06/05/2013 | EP2598483A1 Ampk-activating heterocyclic compounds and methods for using the same |
| 06/05/2013 | EP2598482A1 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use |
| 06/05/2013 | EP2598481A1 Sulfonamide compounds useful as cyp17 inhibitors |
| 06/05/2013 | CN103140487A Process for making linezolid |
| 06/05/2013 | CN103130790A 3-benzo isoxazole-4-benzpyrole maleimide derivative and application thereof |
| 06/05/2013 | CN103130789A Organic semiconductor material containing dibenzothiophene sulfone, preparation method and application thereof |
| 06/05/2013 | CN103130788A Pyrimidine amide compound, and preparation method, anti-HIV activity and anti-TMV activity thereof |
| 06/05/2013 | CN103130787A Pyrimidone amide compound, and preparation method, anti-HIV activity and anti-TMV activity thereof |
| 06/05/2013 | CN103130786A Oxazolidines ionic liquid containing carbonic ester perssad and preparation method and application thereof |
| 06/05/2013 | CN103130785A Preparation method of iloperidone |
| 06/05/2013 | CN103130775A Indolinone derivatives serving as tyrosine kinase inhibitors |
| 06/05/2013 | CN103130735A Modulators of indoleamine 2,3-dioxygenase and methods of using the same |
| 06/05/2013 | CN102134234B Indazolyl urea compounds and preparation method and medicinal use thereof |
| 06/05/2013 | CN101967139B Fluoro methoxylpyrazole-containing o-formylaminobenzamide compound, synthesis method and application thereof |
| 06/05/2013 | CN101842361B Pyrazinone derivatives and their use in the treatment of lung diseases |
| 06/04/2013 | US8455653 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors |
| 06/04/2013 | US8455638 Soluble guanylate cyclase activators |
| 06/04/2013 | US8455525 Selective androgen receptor modulators |
| 06/04/2013 | US8455522 Benzoxazolone derivatives as aldosterone synthase inhibitors |
| 06/04/2013 | US8455520 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment |
| 06/04/2013 | US8455501 N-(5-cycloalkyl)-pyridin-3-yl carboxamides |
| 06/04/2013 | US8455500 3-hydroxy-5-arylisoxazole derivative |
| 06/04/2013 | US8455498 Inhibitors of histone deacetylase |
| 06/04/2013 | US8455486 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 06/04/2013 | US8455485 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 06/04/2013 | US8455484 Selected inhibitors of protein tyrosine kinase activity |
| 06/04/2013 | US8455479 Heterocyclic compounds |
| 06/04/2013 | US8455477 Therapeutic compounds |
| 06/04/2013 | CA2545660C Heterocyclic inhibitors of mek and methods of use thereof |
| 06/04/2013 | CA2545659C Bicyclic inhibitors of mek |
| 06/04/2013 | CA2534885C 2-(quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators |
| 05/30/2013 | WO2013078376A2 Isoxazole treatments for diabetes |
| 05/30/2013 | WO2013076063A1 Novel pyrrolidine derivatives as inhibitors of cathepsin |
| 05/30/2013 | WO2012140596A8 Glycoside derivatives and uses thereof |
| 05/30/2013 | US20130137876 Nitrogen-containing heterocyclic compound and pest control agent |
| 05/30/2013 | US20130137875 Nucleic acid detections and methods of their use |
| 05/30/2013 | US20130137868 Salts of raltegravir |
| 05/30/2013 | US20130137865 Heteroaryl-pyrazole derivative |